Biomarkers for VEGF-Targeted Therapy in Renal Cell Carcinoma: Critical Review of Level of Evidence and Up to Date

By  

Recent Patents on Biomarkers, Vol. 4, Iss. 2, 2014-05 ,pp. : 119-127

Bentham Science Publishers

Access to resources Recommend Favorite

Current Gene Therapy Strategies for Colorectal Cancer

By  

Current Genomics, Vol. 1, Iss. 1, 2000-07 ,pp. : 103-115

Bentham Science Publishers

Access to resources Recommend Favorite

Cloning a calcium channel 2 -3 subunit gene from a putative tumor suppressor gene region at chromosome 3p21.1 in conventional renal cell carcinoma

By Hanke S.   Bugert P.   Chudek J.   Kovacs G.  

Gene, Vol. 264, Iss. 1, 2001-02 ,pp. : 69-75

Elsevier

Access to resources Recommend Favorite

Integrins in Head and Neck Squamous Cell Carcinoma (HNSCC): A Review of the Current Literature

By Georgolios A.   Batistatou A.   Charalabopoulos K.  

Cell Communication and Adhesion, Vol. 12, Iss. 1-2, 2005-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

Cell Cycle Arrest by the PTEN Tumor Suppressor Is Target Cell Specific and May Require Protein Phosphatase Activity

By Hlobilkova A.   Guldberg P.   Thullberg M.   Zeuthen J.   Lukas J.   Bartek J.  

Experimental Cell Research, Vol. 256, Iss. 2, 2000-05 ,pp. : 571-577

Elsevier

Access to resources Recommend Favorite